20 results
PRE 14A
ATHA
Athira Pharma, Inc.
28 Mar 24
Preliminary proxy
8:47am
Communications with the Board of Directors
Policy Prohibiting Hedging or Pledging of Securities
Code of Business Conduct and Ethics
Environmental, Social … Code of Business Conduct and Ethics;
adopts and oversees procedures to address complaints regarding accounting, internal accounting controls
DFAN14A
EX-99.1
Kayne Richard A
4 May 22
Additional proxy materials by non-management
10:56am
, regulatory affairs, drug safety, and medical ethics. Dr. Krall oversaw a budget of over $1.5 billion as part of his drug development and regulatory
DFAN14A
EX-99.1
ejy7um84clfao7znd3v
25 Apr 22
Additional proxy materials by non-management
3:31pm
DFAN14A
EX-99.6
yeff8sla8b4d 68alfbs
22 Apr 22
Additional proxy materials by non-management
10:07am
DEFC14A
sjgmg4tt2b307
5 Apr 22
Proxy in contested solicitation
4:08pm
PREC14A
y4ysy
25 Mar 22
Preliminary proxy with contested solicitation
5:15pm
DEF 14A
24u1bu3h to
16 Apr 21
Definitive proxy
6:02am
10-K
ly4a 9cz8r0smdw
25 Mar 21
Annual report
12:00am
424B4
9b8vbaym
21 Jan 21
Prospectus supplement with pricing info
12:00am
DRS
doejhy5smowkq6i 8atn
6 Jan 21
Draft registration statement
12:00am
424B4
6qk 7hkbgvath
18 Sep 20
Prospectus supplement with pricing info
4:05pm
S-1
d42j6hwyuw67u
26 Aug 20
IPO registration
5:25pm
DRS
9iysmc q0
24 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next